Research and Markets: Concise Analysis of the International Orphan Drugs Industry
BIO Announces New Health Focused Specialty Forums at the 2014 BIO International Convention in San Diego
Veracyte, Inc. to Announce Fourth Quarter and Full-Year 2013 Financial Results and Host Conference Call on Tuesday, March 18, 2014
Alnylam Announces Closing of Previously Announced Alliance with Genzyme for Discovery, Development, and Commercialization of RNAi Therapeutics as Genetic Medicines
Who's in front heading 'round the bend?
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
This screen finds stocks that would make it into Morningstar's Wide-Moat Focus strategy.
Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.
A roundup of investment news.